nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease
|
Lauffenburger, Julie C. |
|
|
228 |
C |
p. 36-43 |
artikel |
2 |
Comparison of optical coherence tomography–guided versus intravascular ultrasound–guided percutaneous coronary intervention: Rationale and design of a randomized, controlled OCTIVUS trial
|
Kang, Do-Yoon |
|
|
228 |
C |
p. 72-80 |
artikel |
3 |
Editorial Board
|
|
|
|
228 |
C |
p. iv |
artikel |
4 |
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
|
Li, Yi |
|
|
228 |
C |
p. 1-7 |
artikel |
5 |
Information for Readers
|
|
|
|
228 |
C |
p. v |
artikel |
6 |
Letter to the editor regarding the study “Impact of time of onset of symptom of ST-segment elevation myocardial infarction on 1-year rehospitalization for heart failure and mortality” published in the American Heart Journal
|
Rossberg, Nora |
|
|
228 |
C |
p. 116 |
artikel |
7 |
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials
|
Ploumen, Eline H. |
|
|
228 |
C |
p. 109-115 |
artikel |
8 |
Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial
|
Li, Yi |
|
|
228 |
C |
p. 8-16 |
artikel |
9 |
Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial
|
Jawitz, Oliver K. |
|
|
228 |
C |
p. 91-97 |
artikel |
10 |
Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry
|
Bhardwaj, Bhaskar |
|
|
228 |
C |
p. 57-64 |
artikel |
11 |
Prevalence of angina and use of medical therapy among US adults: A nationally representative estimate
|
Aggarwal, Rahul |
|
|
228 |
C |
p. 44-46 |
artikel |
12 |
Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve intervention (Randomized researcH in womEn all comers wIth Aortic stenosis [RHEIA] trial)
|
Eltchaninoff, Helene |
|
|
228 |
C |
p. 27-35 |
artikel |
13 |
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease
|
Stähli, Barbara E. |
|
|
228 |
C |
p. 98-108 |
artikel |
14 |
Response to the letter to the editor regarding the study “Impact of time of onset of symptom of ST-segment elevation myocardial infarction on 1-year rehospitalization for heart failure and mortality” published in the American Heart Journal
|
Paradies, Valeria |
|
|
228 |
C |
p. 117-118 |
artikel |
15 |
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis
|
Klein, Allan L. |
|
|
228 |
C |
p. 81-90 |
artikel |
16 |
Smartphone-based application to improve medication adherence in patients after surgical coronary revascularization
|
Yu, Chunyu |
|
|
228 |
C |
p. 17-26 |
artikel |
17 |
Table of Contents
|
|
|
|
228 |
C |
p. i-iii |
artikel |
18 |
The IMPact on Revascularization Outcomes of intraVascular ultrasound-guided treatment of complex lesions and Economic impact (IMPROVE) trial: Study design and rationale
|
Shlofmitz, Evan |
|
|
228 |
C |
p. 65-71 |
artikel |
19 |
Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial
|
Jensen, Jesper |
|
|
228 |
C |
p. 47-56 |
artikel |